Also effective April 1, 2009, Alan MacKenzie will assume the role of EVP, International Operations, responsible for all international (ex-Japan) commercial operations in the United States, Europe, and Asia, as well as global medical affairs and international marketing. The creation of the EVP, International Operations role enhances Takeda's globalization efforts and allows for more streamlined commercial decision making. The EVP, International Operations will be based in the United States at Takeda's Deerfield, Illinois headquarters.
Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals Europe Limited, and Takeda Pharmaceuticals Asia Private Limited will report to EVP, International Operations.
Formerly President and CEO of Takeda Pharmaceuticals North America, Inc. and Executive Vice President of Takeda America Holdings, Inc., Mr. MacKenzie has been with the Takeda family of companies for 24 years. He was a founding executive of Takeda Pharmaceuticals North America, Inc. and past President of TAP Pharmaceutical Products Inc.
Shinji Honda will replace Mr. MacKenzie as CEO, Takeda Pharmaceuticals North America, Inc. Mr. Honda joined Takeda in 1981 and has held a variety of roles in the global organization including Executive Vice President of TAP Pharmaceutical Products Inc. and head of the U.S. Operations Department. Most recently, Mr. Honda was the General Manager of the Overseas Business Planning Department.
Erich Brunn, Ph.D. will continue in his role as CEO of Takeda Pharmaceuticals Europe Limited. Dr. Brunn is responsible for oversight of pan-European sales and marketing. Dr. Brunn was previously President of Takeda Pharma GmbH, a wholly owned subsidiary of Takeda in Germany.
Mr. Stefan Ziegler will continue in his role as CEO of Takeda Pharmaceuticals Asia Private Limited. Mr. Ziegler is responsible for oversight
|SOURCE Takeda Pharmaceutical Company Limited|
Copyright©2009 PR Newswire.
All rights reserved